Motilal Oswal Financial Services recommends buying Ipca Laboratories with a target price of Rs 1980. The company reported strong quarterly financial growth, with a rise in total income and net profit. Key management and strategic moves to optimize operations are expected to drive substantial earnings growth. Ipca is reviving its US business and improving efficiency to enhance profitability.
